Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
about
Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cellsThe central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetesIdentification of cytoskeleton-associated proteins essential for lysosomal stability and survival of human cancer cellsRegulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5The Gβγ-Src signaling pathway regulates TNF-induced necroptosis via control of necrosome translocationDistinct roles of basal steady-state and induced H-ferritin in tumor necrosis factor-induced death in L929 cells.Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma.Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death.Plasma membrane calcium ATPases as novel candidates for therapeutic agent developmentDiscovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.Molecular Mechanism of Cinnamomum verum Component Cuminaldehyde Inhibits Cell Growth and Induces Cell Death in Human Lung Squamous Cell Carcinoma NCI-H520 Cells In Vitro and In VivoCinnamomum verum component 2-methoxycinnamaldehyde: a novel antiproliferative drug inducing cell death through targeting both topoisomerase I and II in human colorectal adenocarcinoma COLO 205 cells.Cuminaldehyde from Cinnamomum verum Induces Cell Death through Targeting Topoisomerase 1 and 2 in Human Colorectal Adenocarcinoma COLO 205 Cells.Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.Plasma membrane calcium pump regulation by metabolic stress.Preeclampsia, placenta, oxidative stress, and PMCA.TG-interacting factor is required for the differentiation of preadipocytes.Cinnamomum verum Component 2-Methoxycinnamaldehyde: A Novel Anticancer Agent with Both Anti-Topoisomerase I and II Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo.Urinary proteins induce lysosomal membrane permeabilization and lysosomal dysfunction in renal tubular epithelial cells.The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease.Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation.Metabolic regulation of the PMCA: Role in cell death and survival.Imaging of intracellular acidic compartments with a sensitive rhodamine based fluorogenic pH sensor.Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killingPlasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells.Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis.Cleavage of the plasma membrane Ca+ATPase during apoptosis.Discovery of a novel anti-cancer agent targeting both topoisomerase I and II in hepatocellular carcinoma Hep 3B cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy.Contribution of caveolin-1 alpha and Akt to TNF-alpha-induced cell death.Co-deficiency of Lysosomal Mucolipins 3 and 1 in Cochlear Hair Cells Diminishes Outer Hair Cell Longevity and Accelerates Age-Related Hearing Loss.Fluorescence imaging lysosomal changes during cell division and apoptosis observed using Nile Blue based near-infrared emission.
P2860
Q24672726-5C5B2797-C13F-4CBE-AEFE-F24F803736E4Q26860579-DCCBE956-0E95-4471-9A67-95D20448BFF1Q28484373-1CBA6F63-82F9-42D0-B705-1C69A4CCAA31Q28592957-D6ECCDB8-4C20-4CCE-9FA5-94A41765790CQ28660413-02AC2B67-09EA-46AA-9AA7-F5F8BBB3D427Q33925223-54228DE0-7C38-45A7-8A62-EE49BD686B0FQ34026072-7A2D3232-D972-4909-AA98-34F5BCDC39CEQ34811905-63F4DEDB-8D8A-413A-ACB1-E627A5C5276DQ34956508-E6964C2E-4E37-41C6-86BD-F1134DB17992Q36451713-2D2C7193-62F2-40FC-A26F-DAA7F7F36D33Q36563889-D02DC7C9-2003-494D-8E0F-DF4C3611792DQ36985331-262310BF-408E-4AB4-BC51-CF41BC6FCA88Q37045056-A10F13DA-FACB-44BA-B2BE-EA82CEAC7968Q37157022-65006AC5-97ED-48A1-B45C-1A528F8E81F2Q37871358-362A9A08-A7FE-4901-8074-FC11558CBE9CQ38016970-53909B43-4DFC-425E-A63A-3DB5D79D19E2Q38293113-9A6B1FC2-F06E-4068-BE05-39852170ACD8Q38811257-51FFDABE-0CD1-46CD-A701-11F78AB07D7FQ38920178-0CBD7833-6E63-4A46-87A5-BD999BC7E07AQ39342378-F7C39DC2-3068-497B-9A03-191A07C293F3Q39357846-6BAA28F9-FB2B-4002-A6BE-4D19A4FACA87Q39380836-FA67FFFF-2449-4190-813D-8CA6302A4A16Q39500384-0D0676FE-414D-483C-8F39-F50CD69C655AQ39629983-465AE183-F324-4EB4-8261-C26B94443D93Q39799396-7EE188E2-23B4-40D4-83C8-684431719313Q39887289-0343060B-9DE4-425C-9B9C-C8C33531F974Q40143487-47599AC1-9F1C-49A6-AAD3-112487738E28Q40168060-F3E4F43B-D9F4-4CA9-AF89-7E46DED0BB68Q40412339-628A7752-FE78-4754-A70E-EB9C5E465A7FQ40578548-2FCC33F6-903A-4F16-948D-635EA77C52E2Q49914916-32F141D2-E2A6-44AA-8327-73073B5E706FQ50227604-F635AAC2-58BC-46E7-8261-02651DE3E019
P2860
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@ast
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@en
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@nl
type
label
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@ast
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@en
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@nl
prefLabel
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@ast
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@en
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@nl
P2093
P2860
P1476
Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.
@en
P2093
P2860
P304
P356
10.1128/MCB.21.24.8276-8288.2001
P407
P577
2001-12-01T00:00:00Z